MusclePharm Corporation Earnings Per Share (Diluted)
MusclePharm Corporation reported Earnings Per Share (Diluted) of -$0.19 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2022-05-16
- MusclePharm Corporation earnings per share, diluted for the quarter ending 2022-03-31 was -$0.19.
- MusclePharm Corporation earnings per share, diluted for the quarter ending 2021-12-31 was -$0.20, a 414.43% decline year-over-year.
- MusclePharm Corporation earnings per share, diluted for the quarter ending 2021-09-30 was -$0.12, a 1300.00% decline year-over-year.
- MusclePharm Corporation earnings per share, diluted for the quarter ending 2021-03-31 was $0.00.
- MusclePharm Corporation earnings per share, diluted for fiscal 2021 was -$0.39, a 657.14% decline from fiscal 2020.
- MusclePharm Corporation earnings per share, diluted for fiscal 2020 was $0.07.
- MusclePharm Corporation earnings per share, diluted for fiscal 2019 was -$0.92.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.19 10-Q · filed 2022-05-16 | -$0.39 derived: net income ÷ weighted average shares · filed 2022-05-16 | -$0.51 derived: net income ÷ weighted average shares · filed 2022-05-16 | ||||
| 2021-12-31 | -$0.20 derived: net income ÷ weighted average shares · filed 2022-05-04 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-05-04 | -$0.39 10-K/A · filed 2022-05-04 | ||||
| 2021-09-30 | -$0.12 10-Q · filed 2021-11-17 | -$0.18 10-Q · filed 2021-11-17 | |||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.06 derived: net income ÷ weighted average shares · filed 2022-05-16 | $0.08 derived: net income ÷ weighted average shares · filed 2022-05-16 | ||||
| 2020-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2022-05-04 | $0.07 derived: net income ÷ weighted average shares · filed 2022-05-04 | $0.07 10-K/A · filed 2022-05-04 | $0.08 10-K · filed 2021-03-29 | |||
| 2020-09-30 | $0.01 10-Q · filed 2021-11-17 | $0.01 10-Q · filed 2021-11-17 | |||||
| 2020-03-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2021-11-17 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-11-17 | -$0.31 derived: net income ÷ weighted average shares · filed 2021-11-17 | ||||
| 2019-12-31 | -$0.11 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-03-29 | -$0.92 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | -$0.27 10-Q · filed 2020-11-24 | -$0.94 10-Q · filed 2020-11-24 | |||||
| 2015-09-30 | -$2.01 10-Q · filed 2015-11-09 | -$2.53 derived: net income ÷ weighted average shares · filed 2016-11-09 | -$3.12 10-Q · filed 2015-11-09 | ||||
| 2015-06-30 | -$0.51 10-Q · filed 2015-08-10 | -$1.08 10-Q · filed 2015-08-10 | |||||
| 2015-03-31 | -$0.56 10-Q · filed 2015-05-11 | ||||||
| 2014-09-30 | $0.05 10-Q · filed 2015-11-09 | -$0.03 derived: net income ÷ weighted average shares · filed 2015-11-09 | $0.20 10-Q · filed 2015-11-09 | ||||
| 2014-06-30 | -$0.09 10-Q · filed 2015-08-10 | $0.03 10-Q · filed 2014-08-05 | $0.15 10-Q · filed 2015-08-10 | $0.27 10-Q · filed 2014-08-05 | |||
| 2014-03-31 | $0.23 10-Q · filed 2015-05-11 | ||||||
| 2013-09-30 | -$0.47 10-Q · filed 2014-11-14 | -$0.81 derived: net income ÷ weighted average shares · filed 2014-11-14 | -$2.07 10-Q · filed 2014-11-14 | ||||
| 2013-06-30 | -$0.34 10-Q · filed 2014-10-31 | -$1.72 10-Q · filed 2014-10-31 | |||||
| 2013-03-31 | -$1.78 10-Q · filed 2014-05-05 |